Tralokinumab Treatment In Patients With Atopic Dermatitis and Moderate-to-Severe Hand Involvement: Results From the 32-week Phase 3b ADHAND Trial. J of Skin [Internet]. 2026 Mar. 10 [cited 2026 Apr. 29];10(2):s744. Available from: https://skin.dermsquared.com/skin/article/view/4105